Epidemiological evidence supports that a higher leptin level was associated with a higher risk of recurrence in all breast cancer patients [14], and a lower adiponectin level was associated with a higher risk of recurrence in hormone receptor-negative breast cancer patients [15]. The gene discussed is ADIPOQ; the disease is breast carcinoma.